Detalhe da pesquisa
1.
The Bidirectional, Absorbable, No-Drain Abdominoplasty.
Aesthetic Plast Surg
; 42(1): 23-31, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29218473
2.
Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer.
Proc Natl Acad Sci U S A
; 111(10): 3865-70, 2014 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-24613931
3.
Structures of intermediate transport states of ZneA, a Zn(II)/proton antiporter.
Proc Natl Acad Sci U S A
; 110(46): 18484-9, 2013 Nov 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24173033
4.
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
Invest New Drugs
; 33(4): 931-41, 2015 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26048096
5.
Rhytidectomy Utilizing Bidirectional Self-Retaining Sutures: The Bidirectional Lift and the Extended Bidirectional Lift.
Aesthet Surg J
; 35(6): 633-43, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26229124
6.
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 15(13): 1433-1441, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25456362
7.
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(12): 1369-78, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25439691
8.
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
Cancer
; 120(8): 1145-54, 2014 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24501009
9.
Structural context shapes the aquaporin selectivity filter.
Proc Natl Acad Sci U S A
; 107(40): 17164-9, 2010 Oct 05.
Artigo
Inglês
| MEDLINE | ID: mdl-20855585
10.
Metal-induced conformational changes in ZneB suggest an active role of membrane fusion proteins in efflux resistance systems.
Proc Natl Acad Sci U S A
; 107(24): 11038-43, 2010 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20534468
11.
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Nat Med
; 29(6): 1400-1411, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37277454
12.
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors.
Protein Sci
; 32(8): e4712, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37354015
13.
Architecture and selectivity in aquaporins: 2.5 a X-ray structure of aquaporin Z.
PLoS Biol
; 1(3): E72, 2003 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-14691544
14.
Glycerol facilitator GlpF and the associated aquaporin family of channels.
Curr Opin Struct Biol
; 13(4): 424-31, 2003 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12948772
15.
Intubating extremely premature newborns: a randomised crossover simulation study.
BMJ Paediatr Open
; 1(1): e000157, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29637161
16.
A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors.
Clin Cancer Res
; 23(5): 1177-1185, 2017 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27733479
17.
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).
Lung Cancer
; 106: 76-82, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28285698
18.
Catalysis, specificity, and ACP docking site of Streptomyces coelicolor malonyl-CoA:ACP transacylase.
Structure
; 11(2): 147-54, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12575934
19.
Crystal Structure of the Human tRNA m(1)A58 Methyltransferase-tRNA(3)(Lys) Complex: Refolding of Substrate tRNA Allows Access to the Methylation Target.
J Mol Biol
; 427(24): 3862-76, 2015 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26470919
20.
Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.
J Thorac Oncol
; 9(10): 1523-31, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25521398